Doubt over the value of HPV jab for teenagers
09 February 2007
Vaccinating teens against HPV will not be cost-effective and could divert resources away from the current cervical screening programme, a public health expert has warned.
The first vaccine against HPV, patented as Gardasil, has received its European licence but the Joint Committee on Vaccination and Immunisation’s HPV subgroup has still to decide whether vaccinating all girls, and perhaps boys, from the age of 11 is to be recommended.
Dr Angela Raffle, public health lead for cervical screening at Bristol PCT, is concerned that giving the vaccine to UK teenagers will more than double the cost of the current cervical cancer control programme ‘for little or no gain’.
But national roll-out of a HPV vaccine was defended by Dr Sarah Jarvis, RCGP women’s health spokeswoman.
‘I would anticipate this is one of the most cost-effective vaccinations in UK history, given the savings in terms of colposcopy and genital wart treatment,’ she said.
Additional Information
Latest jobs Jobs web feed
- Salaried GP The Practice plc £75-85k FTE +NHS pension, Ely or Leicester
- Regional Clinical Leads The Practice plc Salary £95-105k FTE + NHS pension, Leicester or Sheffield
- Salaried/Lead GPs Malling Health Competitive, role dependant, NHS Pension and defence fees reimbursed, Nationwide
- Locums GP Wolverhampton Pegasus Medical £70 per hour, Wolverhampton and West Midlands long term
- Locum GP Leeds and Surrounding Area Pegasus Medical £70 - £75 per hour, Leeds and Yorkshire long term
- Locums GP Walsall Pegasus Medical £70 per hour, Walsall and West Midlands long term
Most read
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
